本页面由Tiger Trade Technology Pte. Ltd.提供服务

众巢医学

0.0260
-0.0102-28.18%
盘后0.0211-0.0049-19.04%19:49 EDT
成交量:1.50亿
成交额:446.87万
市值:10.00万
市盈率:-0.01
高:0.0313
开:0.0313
低:0.0238
收:0.0362
52周最高:12.18
52周最低:0.0238
股本:384.42万
流通股本:233.20万
量比:0.78
换手率:6435.42%
股息:- -
股息率:- -
每股收益(TTM):-1.8500
每股收益(LYR):-1.8500
净资产收益率:-24.88%
总资产收益率:-15.47%
市净率:0.01
市盈率(LYR):-0.01

数据加载中...

2026/06/05

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/22

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2026/05/07

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2026/04/04

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2026/01/15

[修订]年度报告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2025/08/22

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/07/09

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/06/21

SEC问询函

Form CORRESP - Correspondence
2025/06/07

SEC问询函

Form CORRESP - Correspondence
2025/05/20

SEC问询函

Form CORRESP - Correspondence
2025/05/07

SEC问询函

Form CORRESP - Correspondence
2025/04/25

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/02/27

SEC问询函

Form CORRESP - Correspondence
2024/04/30

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/05/12

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/05/09

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/05/21

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/04/30

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/05/08

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/01

非美公司披露报告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]